YaoSale.com’s 12 major predictions for 2019 1) In the past, pharmaceutical companies’ sales were based on preservation and increase, but you may not be able to keep your stock in 2019; 2) In the past, there were bidding advantages for various innovative labels on drugs. In 2019

In 2019, your products (chemical drugs) must pass consistency evaluation; 3) In the past, the market was guaranteed by completing the provincial bidding and centralized procurement. In 2019, it will depend on various GPOs and the gradually expanding national mass procurement. The key is to look at medical insurance.

The face of the bureau; 4) In the past, you had the confidence to deal with the doctor, but in 2019, you have to keep the prescription list in the hospital to feel at ease; 5) In the past, you could go into the hospital and chat with the doctor, but in 2019, you have to explain the practical information under supervision when gradually filing drug registration;

6) In the past, various so-called academic promotion tricks could be mixed up, and it became increasingly difficult to verify the authenticity of various clinical conferences and clinical research in 2019; 7) In the past, the bigger the product (intermediate spread) space, the better the investment. In 2019

The space has become smaller and smaller, and the larger the space, the harder it is to attract investment; 8) In the past, hospitals, especially high-level hospitals, looked down upon the out-of-hospital and grass-roots markets. In 2019, grass-roots and out-of-hospital markets may be your last resort; 9) In the past, pharmaceutical companies still

We can find ways to solve agent rebates. In 2019, pharmaceutical companies will no longer dare to settle bills for agents; 10) In the past, agents had no worries about buying invoices with low tax burdens or issuing invoices from companies. In 2019, various routine tax audits will be carried out

Let "false prescription" no longer be blatant; 11) In the past, natural persons or doctors only wanted to take money privately. In 2019, under financial supervision and the new personal income tax, they will be classified as labor services as wages and pay high personal taxes; 12) In the past,

Pharmaceutical companies and agents are only trying to solve the "fiscal and tax compliance" of ticket payments. In 2019, pharmaceutical companies and agents must return to the "business compliance" of reasonable, compliant and legal product promotion outsourcing and authentic business services.